KyDo Therapeutics

KyDo Therapeutics GmbH (KyDo), a preclinical-stage biotechnology company committed to developing novel covalent-allosteric small molecule inhibitors with the potential to become first-in-class oncology drugs. The Dortmund-based company was jointly founded by LDC together with scientists from the Rau... Read more